A new study by UCLA Health published in Cell presents a major advancement in the future of personalized medicine by pinpointing new connections between people's genes, disease risk and medicine ...
A new study from the Kwon Lab at the Ragon Institute, published in Cell Host & Microbe, provides the most detailed picture ...
Brady Jobe, Senior Associate and Director of Collegiate Projects at Kirksey Architecture, highlights five key trends in ...
VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
Abstract: Printed circuit board (PCB) design software is an important category of electronic design automation (EDA) tool which aims to simplify PCB design through graphical interaction. As a type of ...
VANCOUVER, BC / ACCESS Newswire / January 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
Abstract: This study employs a design science research approach to propose a foundational information system design theory tailored for generative artificial intelligence (GenAI) applications in the ...
In the years after World War II, the legendary Case Study program presented bold new models for modern life, tapping leading architects of the day to design low-cost, efficient residences. The results ...
A study conducted by strategic consultancy firm Roland Berger has confirmed that the small modular reactor proposed by Dutch offshore construction engineering contractor Allseas offers major strategic ...
XS003's NDA acceptance by the FDA marks a significant milestone, with a PDUFA date set for June 18, 2026. XS003 demonstrates bioequivalence to standard nilotinib at a reduced dose, mitigating food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results